NAB1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 6.2494000000024E-05 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.942200E-03 |
Normal-vs-Stage2 |
5.414100E-02 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.285780E-02 |
Stage1-vs-Stage2 |
4.773200E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
1.221590E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
4.967900E-02 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.992800E-04 |
Normal-vs-AfricanAmerican |
9.71199999977301E-07 |
Normal-vs-Asian |
2.979500E-04 |
Caucasian-vs-AfricanAmerican |
3.560700E-03 |
Caucasian-vs-Asian |
5.697600E-01 |
AfricanAmerican-vs-Asian |
7.621300E-03 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.658000E-03 |
Normal-vs-Female |
2.199500E-03 |
Male-vs-Female |
5.656400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.512400E-02 |
Normal-vs-Extreme_Weight |
1.057960E-02 |
Normal-vs-Obese |
1.073780E-02 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
6.703000E-01 |
Normal_Weight-vs-Obese |
1.434370E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
2.969600E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.953400E-01 |
Normal-vs-Age(41-60Yrs) |
2.200200E-02 |
Normal-vs-Age(61-80Yrs) |
1.476190E-03 |
Normal-vs-Age(81-100Yrs) |
5.479400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.997400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.697970E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.394800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.623200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.010400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.438000E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
9.316400E-01 |
Normal-vs-Grade 3 |
8.170600E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
8.138000E-01 |
Grade 2-vs-Grade 4 |
9.316400E-01 |
Grade 3-vs-Grade 4 |
8.170600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.442700E-03 |
Normal-vs-N1 |
1.52639999972948E-07 |
N0-vs-N1 |
4.842900E-04 |
|
|